Segment & Geographic Data Quant-Grade Normalized (live API) API & CSV Delivery

Guardian Pharmacy Services Inc's Business Segments

Guardian Pharmacy Services Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.

Segment Data As of Q1 FY2026
Reportable Segments
1
Per the company's own filing, this quarter
Largest Segment
Corporate
100% of revenue
Total Revenue
$ 337
Consolidated, this quarter
Regions Reported
-
Geographic regions, this quarter
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/GRDN/segments
https://api.csimarket.com/api/v1/companies/GRDN/geographic
https://api.csimarket.com/api/v1/companies/GRDN/exposure
Programmatic access for models, analytics, and integration workflows.
Dataset & schema
https://api.csimarket.com/api/datasets/business_segments
https://api.csimarket.com/api/schema/business_segments
https://api.csimarket.com/api/meta/business_segments

Revenue Share by Reportable Segment - Q1 FY2026

100%largest
  • Corporate100%

Revenue by Reportable Segment - Q1 FY2026

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
CorporateQ1 FY2026$ 337100%-

Description of Guardian Pharmacy Services Inc

Guardian Pharmacy Services, Inc. is a pharmacy services company specializing in technology-enabled support for residents of long-term care facilities (LTCFs) to help ensure adherence to prescribed drug regimens. The company provides clinical, drug dispensing, and administration services primarily to residents in assisted living facilities (ALFs) and behavioral health facilities and group homes (BHFs), which account for over two-thirds of its annual revenue. The remaining revenue is mainly derived from skilled nursing facilities (SNFs). As of December 31, 2025, Guardian operates 61 pharmacies, including 54 full-service locations, serving approximately 205,000 residents in about 8,400 LTCFs across 38 states. The company aims to reduce drug administration errors, manage drug regimen adherence, and lower healthcare costs for residents, LTCFs, and health plan payors. Guardian identifies the ALF and BHF sectors within the U.S. LTCF market as areas with significant growth potential due to their unique challenges.